Skip to main content
Erschienen in: International Ophthalmology 6/2023

10.12.2022 | Original Paper

Complete manuscript title: role of sub-silicone oil application of triamcinolone acetonide (TA) drops on outcomes after 360° relaxing retinectomy: a pilot study

verfasst von: Subhendu Kumar Boral, Deepak Agarwal, Arnab Das, Debdulal Chakraborty

Erschienen in: International Ophthalmology | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To perform a pilot study to evaluate the role of sub-silicone oil Triamcinolone Acetonide (TA) crystal drops in complex Retinal Detachment (RD) with extreme proliferative vitreoretinopathy (PVR) requiring 360-degree relaxing retinectomy (RR).

Design

It was a retrospective pilot study.

Materials and methods

It was a retrospective case–control pilot study. TA-assisted 23G or 25G vitrectomy was done in 24 complex RDs with extreme PVR where 360 degree RR had to be performed. Group A (n = 13) included cases where additional TA crystal drops were applied, after settling the detached retina, over the site of RR under silicone oil (SO 5000 CSt) tamponade. In the control arm, group B (n = 11), additional TA crystals were not applied.
Main outcomes measured.
Mean pre- and post-operative BCVA, ultra-widefield fundus photograph by Optos 200Tx, macular OCT and the propensity to remove silicone oil were measured.

Results

Mean pre-operative and post-operative BCVA at final follow-up were Log MAR 2.69 ± 0.41 and Log MAR 1.51 ± 0.90 (Mann–Whitney U test, p < 0.05), respectively, in Group A and Log MAR 2.9 and Log MAR 2.37 ± 0.86 (Mann–Whitney U test, p < 0.05), respectively, in group B. Visual improvement in group A was significantly better than group B (Wilcoxon W test, p < 0.025) with significantly less recurrence of RD (Fisher’s Exact Test, p = 0.002). Silicone oil removal was done significantly more in group A (Fisher’s Exact Test, p = 0.0017).

Conclusion

Sub-silicone oil crystals application over sites of RR after 360-degree relaxing retinectomy leads to improved postoperative visual recovery as well as improved anatomical outcomes with fewer complications.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wiedemann P, Yandiev Y, Hui YN et al (2013) Pathogenesis of proliferative vitreoretinopathy. In: Ryan SJ (ed) Retina, 5th edn. Mosby Inc, Missouri, pp 1640–1646CrossRef Wiedemann P, Yandiev Y, Hui YN et al (2013) Pathogenesis of proliferative vitreoretinopathy. In: Ryan SJ (ed) Retina, 5th edn. Mosby Inc, Missouri, pp 1640–1646CrossRef
2.
Zurück zum Zitat Hjelmcland LM, Harvey AK (1988) Gliosis of the mammalian retina: migration and proliferation of retinal glia. In: Osborne N, Chader J (eds) Progress in Retinal Research, 7. Pergamon Press, Oxford, pp 259–281 Hjelmcland LM, Harvey AK (1988) Gliosis of the mammalian retina: migration and proliferation of retinal glia. In: Osborne N, Chader J (eds) Progress in Retinal Research, 7. Pergamon Press, Oxford, pp 259–281
3.
Zurück zum Zitat Machemer R (1979) Cutting of the retina: a means of therapy for retinal reattachment [author’s transl]. Klin Monatsbl Augenheilkd 175(5):597–601PubMed Machemer R (1979) Cutting of the retina: a means of therapy for retinal reattachment [author’s transl]. Klin Monatsbl Augenheilkd 175(5):597–601PubMed
4.
Zurück zum Zitat Machemer R, McCuen BW, de Juan E (1986) Relaxing retinotomies and retinectomies. Am J Ophthalmol 102(1):7–12CrossRefPubMed Machemer R, McCuen BW, de Juan E (1986) Relaxing retinotomies and retinectomies. Am J Ophthalmol 102(1):7–12CrossRefPubMed
5.
Zurück zum Zitat Haut J, Seigle P, Larricart P, Flamand M et al (1985) Circular subtotal retinectomy and inferior semicircular retinotomy: preliminary report. Ophthalmologica 191(2):65–74CrossRefPubMed Haut J, Seigle P, Larricart P, Flamand M et al (1985) Circular subtotal retinectomy and inferior semicircular retinotomy: preliminary report. Ophthalmologica 191(2):65–74CrossRefPubMed
6.
Zurück zum Zitat Haut J, Larricart P, Geant G et al (1986) Circular subtotal retinectomy and inferior semicircular retinotomy. Material and results in 38 cases. Ophthalmologica 192(3):129–134CrossRefPubMed Haut J, Larricart P, Geant G et al (1986) Circular subtotal retinectomy and inferior semicircular retinotomy. Material and results in 38 cases. Ophthalmologica 192(3):129–134CrossRefPubMed
7.
Zurück zum Zitat Federman JL, Eagle RC (1990) Jr Extensive peripheral retinectomy combined with posterior 360 degrees retinotomy for retinal reattachment in advanced proliferative vitreoretinopathy cases. Ophthalmology 97(10):1305–1320CrossRefPubMed Federman JL, Eagle RC (1990) Jr Extensive peripheral retinectomy combined with posterior 360 degrees retinotomy for retinal reattachment in advanced proliferative vitreoretinopathy cases. Ophthalmology 97(10):1305–1320CrossRefPubMed
8.
Zurück zum Zitat Kolomeyer AM, Grigorian RA, Mostafavi D et al (2011) 360-degree retinectomy for the treatment of complex retinal detachment. Retina 31(2):266–274CrossRefPubMed Kolomeyer AM, Grigorian RA, Mostafavi D et al (2011) 360-degree retinectomy for the treatment of complex retinal detachment. Retina 31(2):266–274CrossRefPubMed
9.
Zurück zum Zitat Banaee T, Hosseini SM, Eslampoor A et al (2009) Peripheral 360 degrees retinectomy in complex retinal detachment. Retina 29(6):811–818CrossRefPubMed Banaee T, Hosseini SM, Eslampoor A et al (2009) Peripheral 360 degrees retinectomy in complex retinal detachment. Retina 29(6):811–818CrossRefPubMed
10.
Zurück zum Zitat Garnier S, Rahmi A, Grasswil C et al (2013) Three hundred and sixty degree retinotomy for retinal detachments with severe proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 251(9):2081–2085CrossRefPubMed Garnier S, Rahmi A, Grasswil C et al (2013) Three hundred and sixty degree retinotomy for retinal detachments with severe proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 251(9):2081–2085CrossRefPubMed
12.
Zurück zum Zitat Chen W, Chen H, Hou P et al (2011) Midterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathy. Retina 31:1137–1142CrossRefPubMed Chen W, Chen H, Hou P et al (2011) Midterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathy. Retina 31:1137–1142CrossRefPubMed
14.
Zurück zum Zitat Spitzer MS, Kaczmarek R, Yoeruek E et al (2009) The distribution, release kinetics, and biocompatibility of triamcinolone injected and dispersed in silicone oil. Invest Ophthalmol Vis Sci 50(5):2337–2343CrossRefPubMed Spitzer MS, Kaczmarek R, Yoeruek E et al (2009) The distribution, release kinetics, and biocompatibility of triamcinolone injected and dispersed in silicone oil. Invest Ophthalmol Vis Sci 50(5):2337–2343CrossRefPubMed
15.
Zurück zum Zitat Boral SK, Das A, Sinha TS (2014) Sub silicone oil (SO) triamcinolone acetonide (TA) drops over relaxing retinotomy (RR)—a novel approach against proliferative vitreoretinopathy (PVR) in complex retinal detachments (RDS). Ophthalmologica 232(suppl 2):1–98. https://doi.org/10.1159/000368726CrossRef Boral SK, Das A, Sinha TS (2014) Sub silicone oil (SO) triamcinolone acetonide (TA) drops over relaxing retinotomy (RR)—a novel approach against proliferative vitreoretinopathy (PVR) in complex retinal detachments (RDS). Ophthalmologica 232(suppl 2):1–98. https://​doi.​org/​10.​1159/​000368726CrossRef
16.
Zurück zum Zitat Banerjee PJ, Cornelius VR, Phillips R, Lo JW, Bunce C, Kelly J, Murphy C, Edwards RT, Robertson EL, Charteris DG (2016) Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlled trial. Trials 17(1):339CrossRefPubMedPubMedCentral Banerjee PJ, Cornelius VR, Phillips R, Lo JW, Bunce C, Kelly J, Murphy C, Edwards RT, Robertson EL, Charteris DG (2016) Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlled trial. Trials 17(1):339CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Kozak I, Cheng L, Mendez T et al (2006) Evaluation of the toxicity of sub retinal triamcinolone acetonide in the rabbit. Retina 26(7):811–817CrossRefPubMed Kozak I, Cheng L, Mendez T et al (2006) Evaluation of the toxicity of sub retinal triamcinolone acetonide in the rabbit. Retina 26(7):811–817CrossRefPubMed
19.
Zurück zum Zitat Maia M, Penha FM, Farah ME, Dib E, Príncipe A, Filho AASL, Magalhaes O Jr, Freymuller E, Rodrigues EB (2008) Subretinal injection of preservative-free triamcinolone acetonide and supernatant vehicle in rabbits: an electron microscopy study. Graefes Arch Clin Exp Ophthalmol 246:379–388CrossRefPubMed Maia M, Penha FM, Farah ME, Dib E, Príncipe A, Filho AASL, Magalhaes O Jr, Freymuller E, Rodrigues EB (2008) Subretinal injection of preservative-free triamcinolone acetonide and supernatant vehicle in rabbits: an electron microscopy study. Graefes Arch Clin Exp Ophthalmol 246:379–388CrossRefPubMed
20.
Zurück zum Zitat Ejstrup R, La Cour M, Heegaard S et al (2012) Toxicity profiles of subretinal indocyanine green, brilliant blue G, and triamcinolone acetonide: a comparative study. Graefes Arch Clin Exp Ophthalmol 250(5):669–677CrossRefPubMed Ejstrup R, La Cour M, Heegaard S et al (2012) Toxicity profiles of subretinal indocyanine green, brilliant blue G, and triamcinolone acetonide: a comparative study. Graefes Arch Clin Exp Ophthalmol 250(5):669–677CrossRefPubMed
21.
Zurück zum Zitat H Liu; RA Equi; S-I Arai et al. Toxicity of subretinal triamcinolone. 2002 December.Vol 43, ARVO Annual meeting abstract H Liu; RA Equi; S-I Arai et al. Toxicity of subretinal triamcinolone. 2002 December.Vol 43, ARVO Annual meeting abstract
22.
Zurück zum Zitat Eckardt C, Behrendt S, Zwick A (1992) Results of silicone oil removal from eyes treated with retinectomies. Ger J Ophthalmol 1(1):2–6PubMed Eckardt C, Behrendt S, Zwick A (1992) Results of silicone oil removal from eyes treated with retinectomies. Ger J Ophthalmol 1(1):2–6PubMed
Metadaten
Titel
Complete manuscript title: role of sub-silicone oil application of triamcinolone acetonide (TA) drops on outcomes after 360° relaxing retinectomy: a pilot study
verfasst von
Subhendu Kumar Boral
Deepak Agarwal
Arnab Das
Debdulal Chakraborty
Publikationsdatum
10.12.2022
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 6/2023
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-022-02586-x

Weitere Artikel der Ausgabe 6/2023

International Ophthalmology 6/2023 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.